H. Schramek et al., DIFFERENTIAL LONG-TERM REGULATION OF MEK AND OF P42 MAPK IN RAT GLOMERULAR MESANGIAL CELLS, American journal of physiology. Cell physiology, 39(1), 1996, pp. 40-48
Constitutive stimulation of the mitogen-activated protein kinase (MAPK
) activator MAPK/ERK kinase (MEK) is sufficient to promote long-term e
vents such as cell differentiation, proliferation, and transformation.
To evaluate a possible mechanism for the chronic regulation of MEK an
d p42 MAPK, we studied the long-term effects of fetal bovine serum (FB
S), the G protein-coupled receptor agonist endothelin-1 (ET-1), and th
e protein tyrosine kinase-coupled receptor agonist platelet-derived gr
owth factor BE (PDGF BE) on MEK and p42 MAPK in glomerular mesangial c
ells (GMC). FBS, ET-1, and PDGF BB led to a time-dependent increase in
MEK-1 mRNA and protein expression without altering p42 MAPK mRNA and
protein levels. FBS also induced MEK-1 mRNA expression in diverse cell
types, including NIH/3T3 fibroblasts, A7r5 vascular smooth muscle cel
ls, and Chinese hamster ovary cells. In GMC, cycloheximide inhibited M
EK-1 mRNA induction but stimulated p42 MAPK mRNA expression in the abs
ence and presence of FBS, ET-1, or PDGF. The FBS-induced increase in M
EK-1 mRNA was accompanied by a sustained enhancement of MEK activity,
as assessed by the ability of immunoprecipitated p45 MEK to activate r
ecombinant p42 MAPK and hence phosphorylate myelin basic protein, and
p42 MAPK activity. We conclude that, in GMC, MEK-1 acts like a delayed
-early gene and that it can be chronically induced at the mRNA and pro
tein level.